Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Tuberculosis

  • your selections
Clear Search

Filter Results

date

Tags

  • results
CSIS Releases Multimedia, Documents On Global TB

The following blog posts discuss a recent working group, panel, and reports on global tuberculosis (TB). Center for Strategic & International Studies: A Strategic Approach to Global Tuberculosis The CSIS Global Health Policy Center (GHPC) examines how TB relates to U.S. national interests, the structure and effectiveness of U.S. TB…

Prophylactic Therapy With TB Drug Effective In HIV Patients, Study Shows

Bloomberg News: Combining Tuberculosis Treatment With HIV Therapy Cuts Disease “The use of tuberculosis drug isoniazid in conjunction with antiretroviral therapy to prevent the disease among HIV-infected patients is safe and cuts the incidence of TB by 37 percent, according to a study…” (Kew, 6/6).

Treatment Action Group Releases TB Drug Guide

Center for Global Health Policy’s “Science Speaks”: TAG’s TB drug guide aims to equip activists Rabita Aziz, policy research coordinator for the Center for Global Health Policy, discusses the Treatment Action Group’s newly released publication titled, “An Activists Guide to TB Drugs” (6/4).

Al Jazeera America Examines Challenges To Preventing, Treating TB In Vietnam

Al Jazeera America: TB is a ‘neglected disease’ in Vietnam despite death toll “Tuberculosis, or TB, is the world’s second-deadliest infectious disease and kills 1.4 million people every year, according to the World Health Organization. While its bacteria are easily transmitted through the air, the disease can be readily treated…

Blog Examines How Mumbai Is Preventing, Treating Drug-Resistant TB

Center for Global Health Policy’s “Science Speaks”: When XDR-TB spread in Mumbai, “lots of togetherness” led to a path of solutions Antigone Barton, writer and editor of “Science Speaks” and senior communications officer at the Center for Global Health Policy, writes about how Mumbai TB officer Minni Khetarpal is preventing…

TV News Stations Feature Shows On Polio, Drug-Resistant TB

Two television news stations feature shows on global health issues. Al Jazeera: Lifelines: The Last Drops “…Pakistan is one of the last countries never to have ended polio despite concerted vaccination efforts from local, national and international organizations…” (5/28). CNN: Vital Signs: Return of the ‘White Plague': Fears over the…

New Drugs Approved To Treat TB; Access To Treatment Still Uncertain

Center for Global Health Policy’s “Science Speaks”: TB drug approvals, distribution deal inches options forward, but MDR-TB treatment access still uncertain where needed most Antigone Barton, writer and editor of “Science Speaks” and senior communications officer at the Center for Global Health Policy, discusses recent TB drug approvals and potential…

UNITAID Grants Aim To Improve Health Therapy Access

The Center for Global Health Policy’s “Science Speaks” discusses recent grants from UNITAID totaling $160 million aimed at improving access to treatments for drug-resistant tuberculosis (TB), hepatitis C, and other therapies (Barton, 5/7).

Governments, NGOs Must Account For TB Funding, Measure Programmatic Impacts

Huffington Post: Where Has All the Money Gone for Fighting Tuberculosis? Shelly Batra, founder and president of Operation ASHA “…Huge amounts of funds have been poured into a bottomless pit [in the name of TB elimination]. … This funding should have led to better outcomes, i.e. improved case detection and…

UNITAID Approves $160M For Investments In Hepatitis C, TB, Malaria

UNITAID has committed $160 million in new grants for investments in hepatitis C, drug-resistant tuberculosis, and malaria chemoprevention. According to a press release, “These innovative investments will reduce prices, overcome market barriers to access for patients, and generate crucial data on new products to speed up their introduction for those…